세계의 산소 부화 회수 시장 예측(-2032년) : 제품별, 유통 채널별, 기술별, 용도별, 최종사용자별, 지역별 분석

According to Stratistics MRC, the Global Oxygen-Enriched Recovery Market is accounted for $41.74 billion in 2025 and is expected to reach $61.45 billion by 2032 growing at a CAGR of 5.68% during the forecast period. Oxygen-Enriched Recovery refers to a therapeutic or technological approach aimed at enhancing the body's recovery process by increasing the availability of oxygen to tissues. This method can involve the use of supplemental oxygen, oxygen-enriched environments, or devices that improve oxygen delivery at the cellular level, accelerating healing and reducing fatigue. It is commonly applied in medical rehabilitation, sports recovery, and critical care settings to support tissue repair, reduce inflammation, and improve overall metabolic function. By optimizing oxygen levels, oxygen-enriched recovery aids in faster recuperation, improved performance, and enhanced physiological resilience.

Market Dynamics:

Driver:

Rising respiratory & chronic disease burden

Patients with chronic conditions often require supplemental oxygen therapy to improve lung function and overall recovery. Hospitals and clinics are adopting oxygen-enriched recovery systems to enhance patient outcomes and reduce hospitalization time. Aging populations and higher incidence of lifestyle-related diseases further drive market growth. Technological advancements in portable and efficient oxygen delivery systems make treatments more accessible. Overall, the growing respiratory and chronic disease burden is directly propelling the expansion of the market.

Restraint:

Regulatory hurdles & safety standards

Manufacturers must comply with complex medical device regulations, which can delay product approvals. Lengthy certification processes increase development costs and extend time-to-market. Variations in regulations across countries create challenges for global distribution. Strict safety standards may limit the adoption of innovative or experimental devices. Overall, these regulatory and compliance requirements act as barriers, restricting rapid market expansion.

Opportunity:

Growth of home-based and portable oxygen devices

Growing awareness of respiratory health and the benefits of recovery is encouraging more consumers to adopt these devices. The convenience of portable oxygen units allows patients and athletes to receive therapy beyond clinical settings. Advances in technology have enhanced the efficiency, safety, and ease of use of these devices. Increased demand in areas such as rehabilitation, sports recovery, and management of chronic illnesses is driving market growth. Additionally, cost-effective and compact designs make these devices accessible to a wider audience, supporting sustained market expansion.

Threat:

Logistics & deployment challenges

Complex supply chains can delay the delivery of devices to end-users, affecting timely access. High transportation costs and regulatory hurdles in different regions increase operational difficulties. Limited availability of trained personnel for setup and maintenance reduces effective deployment. Inadequate infrastructure in remote or rural areas restricts market reach. These combined factors slow adoption rates and limit overall market growth.

Covid-19 Impact:

The Covid-19 pandemic significantly impacted the oxygen-enriched recovery market, driving heightened demand due to respiratory complications among patients. Hospitals, clinics, and emergency care centers increasingly adopted oxygen-enriched therapies to manage severe cases, which accelerated the adoption of related devices and technologies. However, supply chain disruptions, limited availability of equipment, and logistic constraints initially hampered growth. The crisis also spurred innovation, with manufacturers enhancing production capacities and developing portable solutions. Post-pandemic, increased awareness of respiratory health continues to support sustained demand across healthcare and wellness sectors.

The oxygen concentrators segment is expected to be the largest during the forecast period

The oxygen concentrators segment is expected to account for the largest market share during the forecast period due to continuous supply of medical-grade oxygen to patients and wellness users. Their portability and ease of use make them highly attractive for home healthcare and sports recovery applications. Advanced technologies in concentrators improve oxygen purity and delivery efficiency, enhancing user outcomes. Rising awareness of respiratory health and recovery benefits boosts demand for these devices globally. Additionally, cost-effectiveness compared to other oxygen delivery systems further strengthens their market adoption.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate by increasing accessibility to oxygen therapy products for patients outside clinical settings. Growing demand for convenient, at-home treatments encourages manufacturers to innovate portable oxygen concentrators and liquid oxygen systems. Rising awareness about chronic respiratory conditions and post-surgery recovery fuels adoption in residential care. Home healthcare solutions also reduce hospital visits, making oxygen-enriched recovery more cost-effective and patient-friendly. Overall, this segment drives market growth by combining convenience, safety, and efficiency for end-users.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share by established healthcare systems and high demand for advanced oxygen therapy solutions. Widespread adoption of hyperbaric oxygen chambers and liquid oxygen systems in hospitals and clinics boosts growth. The market benefits from strong R&D initiatives, technological innovations, and increasing focus on wellness and sports recovery. Regulatory frameworks ensure product quality and safety, though high device costs and insurance limitations may pose challenges. Overall, the region maintains steady market growth with innovation-driven adoption and a strong healthcare infrastructure.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rising awareness of respiratory health and increasing adoption of oxygen-enriched recovery solutions in home healthcare and sports rehabilitation. Investments in healthcare infrastructure and the presence of emerging local manufacturers are accelerating market expansion. Technological innovations, such as portable concentrators and advanced hyperbaric chambers, are gaining traction. However, logistical challenges and high costs of advanced devices may hinder adoption. Overall, the region shows a dynamic and evolving market landscape with significant growth potential.

Key players in the market

Some of the key players in Oxygen-Enriched Recovery Market include Air Products and Chemicals, Linde plc, Praxair Technology, Air Liquide S.A., Messer Group GmbH, Taiyo Nippon Sanso, Oxair Gas Systems Pte Ltd, Universal Industrial Gases, Parker Hannifin Corporation, Chart Industries, Inc., Cryogenic Industries, Matheson Tri-Gas, Inc., Airgas, Inc., Siemens Energy AG, General Electric Company, Oxymat A/S, Novair Group, PCI Gases, Delta Electronics and Oxywise s.r.o.

Key Developments:

In August 2025, Air Products signed a joint development agreement with ACWA Power and OQ to advance clean energy infrastructure in the Middle East. This strategic move supports the deployment of oxygen-enriched technologies in hydrogen and sulfur recovery units, boosting operational efficiency and significantly reducing emissions.

In June 2025, Praxair launched the I-SO(TM) mechanical oxygenator, capable of dissolving up to 82% high-purity oxygen into wastewater. This enhances biological treatment capacity in refinery wastewater, supporting oxygen-enriched recovery and VOC reduction.

In October 2024, Linde signed agreements to de-captivate two air separation units (ASUs) and expand oxygen supply to Tata Steel in Odisha, India. This initiative ensures consistent, large-scale oxygen delivery for steelmaking and sulfur recovery, enhancing energy efficiency and supporting Tata Steel's decarbonization roadmap.

Products Covered:

• Oxygen Concentrators
• Hyperbaric Oxygen Chambers
• Liquid Oxygen Systems
• Oxygen Cylinders
• Other Products

Distribution Channels Covered:

• Online Retail
• Offline Retail
• Direct Sales

Technologies Covered:

• Pressure Swing Adsorption (PSA)
• Vacuum Swing Adsorption (VSA)
• Cryogenic
• Other Technologies

Applications Covered:

• Sports Recovery
• Post-Surgery Recovery
• Chronic Disease Management
• Wellness & Spa
• Other Applications

End Users Covered:

• Hospitals & Clinics
• Sports & Fitness Centers
• Rehabilitation Centers
• Home Healthcare
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 Technology Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Oxygen-Enriched Recovery Market, By Product

• 5.1 Introduction
• 5.2 Oxygen Concentrators
• 5.3 Hyperbaric Oxygen Chambers
• 5.4 Liquid Oxygen Systems
• 5.5 Oxygen Cylinders
• 5.6 Other Products

6 Global Oxygen-Enriched Recovery Market, By Distribution Channel

• 6.1 Introduction
• 6.2 Online Retail
• 6.3 Offline Retail
• 6.4 Direct Sales

7 Global Oxygen-Enriched Recovery Market, By Technology

• 7.1 Introduction
• 7.2 Pressure Swing Adsorption (PSA)
• 7.3 Vacuum Swing Adsorption (VSA)
• 7.4 Cryogenic
• 7.5 Other Technologies

8 Global Oxygen-Enriched Recovery Market, By Application

• 8.1 Introduction
• 8.2 Sports Recovery
• 8.3 Post-Surgery Recovery
• 8.4 Chronic Disease Management
• 8.5 Wellness & Spa
• 8.6 Other Applications

9 Global Oxygen-Enriched Recovery Market, By End User

• 9.1 Introduction
• 9.2 Hospitals & Clinics
• 9.3 Sports & Fitness Centers
• 9.4 Rehabilitation Centers
• 9.5 Home Healthcare
• 9.6 Other End Users

10 Global Oxygen-Enriched Recovery Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Air Products and Chemicals, Inc.
• 12.2 Linde plc
• 12.3 Praxair Technology, Inc.
• 12.4 Air Liquide S.A.
• 12.5 Messer Group GmbH
• 12.6 Taiyo Nippon Sanso Corporation
• 12.7 Oxair Gas Systems Pty Ltd
• 12.8 Universal Industrial Gases, Inc.
• 12.9 Parker Hannifin Corporation
• 12.10 Chart Industries, Inc.
• 12.11 Cryogenic Industries, Inc.
• 12.12 Matheson Tri-Gas, Inc.
• 12.13 Airgas, Inc.
• 12.14 Siemens Energy AG
• 12.15 General Electric Company
• 12.16 Oxymat A/S
• 12.17 Novair Group
• 12.18 PCI Gases
• 12.19 Delta Electronics, Inc.
• 12.20 Oxywise s.r.o.